DOI: https://doi.org/10.22141/2224-0551.1.60.2015.74927

Novirin Effectiveness in Children with Viral Diarrhea

S.O. Kramariov, V.V. Yevtushenko, O.M. Yevtushenko, Ye.A. Maievska, V.V. Babak

Abstract


The article deals with the issues of treatment for viral diarrhea. The main direction in the treatment of acute viral intestinal infections is the use of rehydration and drugs for symptomatic therapy. Also, research data repeatedly confirmed the effectiveness of antiviral agents. In recent years, inosine pranobex, an antiviral agent with immunomodulating properties, is being successfully used for the treatment of viral diseases in children. In the present study, the authors demonstrated the effectiveness of Novirin (inosine pranobex) in the treatment of viral diarrhea in children: administration of Novirin made it possiblee to stop diarrhea in the first 5 days after treatment initiation in significantlylarger number of children (80 %) compared with the control group (43 %).

Keywords


diarrhea; children; antiviral agents; inosine pranobex.

References


Anlar B. Subacute sclerosing panencephalitis and chronic viral encephalitis // Handb. Clin. Neurol. — 2013. — 112. — 1183-9. doi:10.1016/B978-0-444-52910-7.00039-8.

Aronson J.K. Meyler’s. Side Effects of Antimicrobial Drugs. Elsevier; 2010. Available at: https://books.google.com.ua/books?id=aYh5NwAACAAJ.

Black R.E., Cousens S., Johnson H.L. et al. Global, regional, and national causes of child mortality in 2008: a systematic analysis // Lancet. — 2010. — 375(9730). — 1969-87. doi:10.1016/S0140-6736(10)60549-1.

Georgala S., Katoulis A.C., Befon A., Georgala C., Rigopoulos D. Oral inosiplex in the treatment of cervical condylomata acuminata: a randomised placebo-controlled trial // BJOG. — 2006. — 113(9). — 1088-91. doi:10.1111/j.1471-0528.2006.01041.x.

Georgala S., Katoulis A.C., Befon A., Georgala K., Stavropoulos P.G. Inosiplex for treatment of alopecia areata: a randomized placebo-controlled study // Acta Derm. Venereol. — 2006. — 86(5). — 422-4. doi:10.2340/00015555-0138.

Gołebiowska-Wawrzyniak M., Markiewicz K., Kozar A. et al. Immunological and clinical study on therapeutic efficacy of inosine pranobex // Pol. Merkur. Lekarski. — 2005. — 19(48, 22). — 379-382.

Guarino A., Ashkenazi S., Gendrel D., Lo Vecchio A., Shamir R., Szajewska H. ESPGHAN/ESPID Evidence-based Guidelines for the Management of Acute Gastroenteritis in Children in Europe: Update 2014 // J. Pediatr. Gastroenterol. Nutr. — 2014. — 39(1). — 132-152. doi:10.1097/MPG.0000000000000375.

Gutierrez J., Issacson R.S., Koppel B.S. Subacute sclerosing panencephalitis: an update // Dev. Med. Child Neurol. — 2010. — 52(10). — 901-7. doi:10.1111/j.1469-8749.2010.03717.x.

Harukawa H., Yuasa T. Progress of the therapy for virus related neurological disorders // Nihon Rinsho. — 1997. — 55(4). — 959-66. Available at: http://www.ncbi.nlm.nih.gov/pubmed/9103902. Accessed February 8, 2015.

Hosoya M. Anti SSPE drugs // Nihon. Rinsho. — 2012. — 70(4). — 625-8. Available at: http://www.ncbi.nlm.nih.gov/pubmed/22568144. Accessed February 8, 2015.

Hosoya M. Subacute sclerosing panencephalitis (SSPE) // Rinsho Shinkeigaku. — 2011. — 51(11). — 1047-50. Available at: http://www.ncbi.nlm.nih.gov/pubmed/22277474. Accessed February 8, 2015.

Hozyasz K.K., Gryglicka H., Radomyska B. Benign acute childhood myositis (BACM) — cases report // Pol. Merkur. Lekarski. — 2009. — 27(158). — 129-31. Available at: http://www.ncbi.nlm.nih.gov/pubmed/19856879. Accessed February 8, 2015.

Iakupova R.S., Skachkova M.A., Choloian S.B., Karpova E.G. Efficacy of immunomodulators in children with respiratory diseases in environmentally poor areas // Gig. Sanit. — 2012. — (3). — 33-4. Available at: http://www.ncbi.nlm.nih.gov/pubmed/23088120. Accessed February 8, 2015.

Linhares R.E.C., Rebelle M.A., Nozawa C.M. Effect of isoprinosine on rotavirus replication in vitro // Brazilian J. Med. Biol. Res. — 1996. — 29. — 219-222.

Ohnishi H., Kosuzume H., Inaba H., Ohkura M., Shimada S., Suzuki Y. The immunomodulatory action of inosiplex in relation to its effects in experimental viral infections // Int. J. Immunopharmacol. — 1983. — 5(3). — 181-96. Available at: http://www.ncbi.nlm.nih.gov/pubmed/6194125. Accessed February 8, 2015.

Orbuch M. Diarrheal Diseases // Gastroenterol. Nurs. — 1992. — 14. — 316. doi:10.1097/00001610-199206000-00011.

Stenzel T., Tykałowski B., Smiałek M., Koncicki A., Kwiatkowska-Stenzel A. The effect of different doses of methisoprinol on the percentage of CD4+ and CD8+ T lymphocyte subpopulation and the antibody titers in pigeons immunised against PPMV-1 // Pol. J. Vet. Sci. — 2011. — 14(3). — 367-71. Available at: http://www.ncbi.nlm.nih.gov/pubmed/21957729. Accessed February 8, 2015.

Thorsen S., Pedersen C., Sandström E. et al. Controlled, clinical trial of isoprinosine administration to HIV-infected patients. Results of a Danish/Swedish multicenter study. The Scandinavian Isoprinosine Study Group // Ugeskr Laeger. — 1994. — 156(22). — 3314-8. Available at: http://www.ncbi.nlm.nih.gov/pubmed/7520643. Accessed February 8, 2015.

WHO. Diarrhoeal disease. Available at: http://www.who.int/mediacentre/factsheets/fs330/en/. Accessed December 28, 2014.

Леваков С.А., Кедрова А.Г., Кажурина Е.В., Ванке Н.С. Синтетические аналоги инозина в современном лечении фоновых и предраковых заболеваний шейки матки // Клиническая практика. — 2010. — № 3. — С. 43-50.

Інфекційні хвороби в дітей: Підручник / С.О. Крамарьова, О.Б. Надрага, Л.В. Пипа [та ін.]; За ред. проф. С.О. Крамарьова, О.Б. Надраги. — К.: ВСВ «Медицина», 2010. — С. 392.

Учайкин В.Ф., Новокшонов А.А., Соколова Н.В. Этиопатогенетическая терапия острых кишечных инфекций у детей на современном этапе // Лечащий врач. — 2010. — № 1. — С. 7-13.




Copyright (c) 2016 CHILD`S HEALTH

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

 

© Publishing House Zaslavsky, 1997-2018

 

   Seo анализ сайта